View More Recent Stories

Sep 25, 2023 08:32AM Ainos (AIMD) Announces Placement of Initial $3M Tranche of $10M Private Placement
Sep 25, 2023 08:30AM Ainos Announces Placement of Initial $3 Million Tranche of $10 Million Private Placement
Sep 18, 2023 07:03AM Ainos (AIMD) Granted FDA Orphan Drug Designation for VELDONA
Sep 18, 2023 07:00AM Ainos’ VELDONA Granted Orphan Drug Designation by U.S. FDA for Potential Treatment of Oral Warts in HIV-Seropositive Patients
Sep 5, 2023 07:00AM Ainos Commences Shipping its VELDONA Pet Cytoprotein Supplements in Taiwan
Aug 11, 2023 04:33PM Ainos (AIMD) Reports Q2 Results
Aug 11, 2023 04:30PM Ainos Reports Second Quarter 2023 Financial Results
Aug 10, 2023 08:00AM Ainos Celebrates First Listing Anniversary on Nasdaq
Aug 9, 2023 08:05AM Ainos (AIMD) Partners with Nisshinbo Micro Devices and Inabata to Co-Develop VOC Sensing Platform For Broader Industry Adoption
Aug 9, 2023 08:00AM Ainos Partners with Nisshinbo Micro Devices and Inabata to Co-Develop VOC Sensing Platform For Broader Industry Adoption
Jun 27, 2023 08:32AM Ainos (AIMD) Issues Mid-Year Business Update Letter to Shareholders
Jun 27, 2023 08:30AM Ainos Issues Mid-Year Business Update Letter to Shareholders
Jun 20, 2023 08:30AM Ainos Provides Insights Into Its AI Nose Technology
Jun 14, 2023 09:00AM Ainos Completes VELDONA Pet Line-Up by Launching New VELDONA Pet Shiny and Slim in Push Towards $20M Revenue Target
Jun 7, 2023 09:00AM Ainos Launches New VELDONA Pet Lohas and Soothing Health Supplements, Catalyzing Its Drive to $20M Sales Target
May 30, 2023 09:00AM Ainos Launches VELDONA Pet Cytoprotein Health Supplement Targeting $20M in Sales
May 17, 2023 04:33PM Ainos (AIMD) Appoints Amanda Sung as New Chief Financial Officer
May 17, 2023 04:30PM Ainos Appoints Amanda Sung as New Chief Financial Officer
May 12, 2023 04:15PM Ainos Reports First Quarter 2023 Financial Results
View More Recent Stories